Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T14:51:41.279Z.
Calculation as of: 2026-10-06T14:51:41.279Z.
Quote observation: 2026-10-06T14:48:29.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1c853c120bd8ccf37c7f587defdd96232933b3c15f4f3e57031eea60a2967291
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-08-14.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
3.45x
EV/FCF RATIO AVG 3Y
3.45x
EV/FCF RATIO AVG 5Y
3.45x
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$13.72M
EV/FCF Ratio
11.16x
TTM Avg
13.15x
3Y Avg
13.15x
5Y Avg
13.15x
Market Cap
$11.31M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.26M
EV/FCF Ratio
N/A
TTM Avg
5.23x
3Y Avg
5.23x
5Y Avg
5.23x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dare Bioscience, Inc. (DARE) | $12.32M | N/A | 3.45x | 3.45x | 3.45x |
| Cytosorbents Corporation (CTSO)vs › | $12.99M | N/A | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.41M | N/A | 7.58x | 7.58x | 7.58x |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.70M | N/A | N/A | N/A | N/A |
| Lantern Pharma Inc. (LTRN)vs › | $11.83M | N/A | N/A | N/A | N/A |
| IN8bio, Inc. (INAB)vs › | $13.47M | N/A | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.72M | 11.16x | 13.15x | 13.15x | 13.15x |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.31M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.26M | N/A | 5.23x | 5.23x | 5.23x |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.93M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2025-08-14 | 2.96x |
| 2025-08-13 | 3.02x |
| 2025-08-12 | 2.89x |
| 2025-08-11 | 2.80x |
| 2025-08-08 | 2.72x |
| 2025-08-07 | 2.91x |
| 2025-08-06 | 3.26x |
| 2025-08-05 | 3.49x |
| 2025-08-04 | 3.47x |
| 2025-08-01 | 3.52x |
| 2025-07-31 | 3.49x |
| 2025-07-30 | 3.46x |
| 2025-07-29 | 3.62x |
| 2025-07-28 | 3.73x |
| 2025-07-25 | 3.76x |
| 2025-07-24 | 3.86x |
| 2025-07-23 | 3.91x |
| 2025-07-22 | 3.83x |
| 2025-07-21 | 3.94x |
| 2025-07-18 | 3.68x |
| 2025-07-17 | 3.65x |
| 2025-07-16 | 3.84x |
| 2025-07-15 | 4.20x |
| 2025-07-14 | 4.60x |
| 2025-07-11 | 3.68x |
| 2025-07-10 | 3.47x |
| 2025-07-09 | 3.55x |
| 2025-07-08 | 3.49x |
| 2025-07-07 | 3.49x |
| 2025-07-03 | 3.49x |
| 2025-07-02 | 3.49x |
| 2025-07-01 | 3.44x |
| 2025-06-30 | 3.47x |
| 2025-06-27 | 3.44x |
| 2025-06-26 | 3.86x |
| 2025-06-25 | 3.87x |
| 2025-06-24 | 3.92x |
| 2025-06-23 | 3.75x |
| 2025-06-20 | 4.16x |
| 2025-06-18 | 4.32x |
| 2025-06-17 | 4.28x |
| 2025-06-16 | 4.40x |
| 2025-06-13 | 4.50x |
| 2025-06-12 | 4.65x |
| 2025-06-11 | 4.85x |
| 2025-06-10 | 4.76x |
| 2025-06-09 | 4.66x |
| 2025-06-06 | 4.77x |
| 2025-06-05 | 4.87x |
| 2025-06-04 | 4.61x |
| 2025-06-03 | 4.60x |
| 2025-06-02 | 4.50x |
| 2025-05-30 | 4.40x |
| 2025-05-29 | 4.26x |
| 2025-05-28 | 4.24x |
| 2025-05-27 | 4.13x |
| 2025-05-23 | 4.29x |
| 2025-05-22 | 4.29x |
| 2025-05-21 | 4.28x |
| 2025-05-20 | 4.28x |
| 2025-05-19 | 4.32x |
| 2025-05-16 | 4.28x |
| 2025-05-15 | 4.26x |
| 2025-05-14 | 4.28x |
| 2025-05-13 | 2.39x |
| 2025-05-12 | 2.37x |
| 2025-05-09 | 2.43x |
| 2025-05-08 | 2.45x |
| 2025-05-07 | 2.39x |
| 2025-05-06 | 2.41x |
| 2025-05-05 | 2.65x |
| 2025-05-02 | 2.57x |
| 2025-05-01 | 2.47x |
| 2025-04-30 | 2.51x |
| 2025-04-29 | 2.43x |
| 2025-04-28 | 2.39x |
| 2025-04-25 | 2.59x |
| 2025-04-24 | 2.61x |
| 2025-04-23 | 2.63x |
| 2025-04-22 | 2.55x |
| 2025-04-21 | 2.55x |
| 2025-04-17 | 2.41x |
| 2025-04-16 | 2.43x |
| 2025-04-15 | 2.51x |
| 2025-04-14 | 2.47x |
| 2025-04-11 | 2.49x |
| 2025-04-10 | 2.39x |
| 2025-04-09 | 2.51x |
| 2025-04-08 | 2.41x |
| 2025-04-07 | 2.39x |
| 2025-04-04 | 2.41x |
| 2025-04-03 | 2.47x |
| 2025-04-02 | 2.43x |
| 2025-04-01 | 2.41x |
| 2018-10-16 | 0.03x |
| 2018-10-15 | 0.05x |
| 2018-09-06 | 0.03x |
| 2018-09-05 | 0.01x |
| 2018-09-04 | 0.00x |
| 2018-08-31 | 0.01x |
| 2018-08-23 | 0.00x |
| 2018-08-20 | 0.00x |
